<DOC>
	<DOCNO>NCT02156544</DOCNO>
	<brief_summary>The purpose study investigate safety/tolerability pharmacokinetics/pharmacodynamics CKD-519 .</brief_summary>
	<brief_title>Study Investigate Safety/Tolerability Pharmacokinetics/Pharmacodynamics CKD-519</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>1 . Between 19 age 55 age healthy adult 2 . Body weight 55kg male , 50kg female 3 . Body Mass Index 18.5 25 ( body mass index=kg/m2 ) 4 . If female , must include one among item The menopause ( natural menses least 2 year ) Surgical Infertility ( hysterectomy bilateral oophorectomy , tubal ligation method infertility condition 5 . If men sexual life woman childbearing age , Necessarily agree use condom sperm donation two month clinical trial final dosage investigational product 6 . Those fully understand clinical trial enough hearing , decide join clinical trial comply precaution write consent 1 . Have clinically significant disease hepatobiliary system ( severe hepatic impairment , etc ) , kidney ( severe renal impairment , etc ) , nervous system , immune system , respiratory system , endocrine system , hematooncology disease , cardiovascular system ( heart failure , etc ) mental illness , history mental disease . 2 . Have gastrointestinal disease history effect drug absorption ( Crohn 's disease , ulcer , etc . ) surgery ( except simple appendectomy hernia surgery ) 3 . Hypersensitivity reaction clinically significant hypersensitivity reaction history drug additives . 4 . An impossible one participate clinical trial include screen test ( medical history taking , BP , 12lead ECG , physical examination , blood &amp; urine laboratory test result ) 28 day take investigational Products . 5 . Defined follow laboratory parameter AST , ALT &gt; 1.25* upper limit normal range Total bilirubin &gt; 1.5* upper limit normal range CPK &gt; 1.5* upper limit normal range eGFR ( use MDRD method ) &lt; 60mL/min/1.73m2 6 . Sitting SBP &gt; 150mmHg &lt; 90mmHg , sit DBP &gt; 100mmHg &lt; 50mmHg , 5 minute break . 7 . Drug abuse history drug abuse showes positive urine drug test . 8 . Pregnant lactating woman . 9 . A heavy caffeine consumer ( caffeine &gt; 5 cups/day ) , alcohol consumer ( alcohol &gt; 210g/week ) , smoker ( cigarette &gt; 10 cigarettes/day ) 10 . Subject take ethical drug herbal medicine within 14 day , OTC within 7 day begin study treatment investigator determine take drug affect study could affect safety subject . 11 . Subject take inhibitor inducer drug metabolize enzyme ( Barbiturates etc . ) within 30 day . 12 . Taking food contain grapefruit within 7 day begin study treatment ( ex . Drinking contain grapefruit 1L per day within 7 day begin study treatment ) 13 . Subject treat investigational drug within 60 day begin study treatment ( However , biologicals applies 90 day , base extended period time consider halflife ) 14 . Previously donate whole blood within 60 day component blood within 30 day . 15 . An impossible one participant clinical trial investigator 's decision include laboratory test result another reason . 16 . Positive Serology test ( Hepatitis B , Hepatitis C , HIV )</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>